发布时间
2026/03/25 04:5812 分钟前源站更新
2026/03/25 04:5812 分钟前首次抓取
2026/03/25 04:5812 分钟前发布时间
12 分钟前源站更新
12 分钟前首次抓取
12 分钟前用于追踪这条内容的来源与记录标识。
Source
原始链接
发布时间
2026/03/25 04:5812 分钟前源站更新
2026/03/25 04:5812 分钟前首次抓取
2026/03/25 04:5812 分钟前发布时间
12 分钟前源站更新
12 分钟前首次抓取
12 分钟前用于追踪这条内容的来源与记录标识。
Source
原始链接
The Big Take The Billion-Dollar Peptide Craze Could Get Even Bigger On today’s Big Take podcast: Peptides are everywhere, but many are unregulated. That could change.
发布时间
98 天前
2026-07-02 22:01:22 UTC
源站更新
98 天前
2026-07-02 22:01:22 UTC
首次抓取
98 天前
2026-07-02 22:58:26 UTC
肽类产品在短短几年间从健身圈和“颜值提升”人群中的小众药物，扩张为一个价值数十亿美元的黑市。随着监管可能到来，医疗行业参与者和投资者正加速布局，而其安全隐忧也受到关注。
Peptides have quickly evolved from fringe drugs favored by fitness buffs and “looksmaxxers” into a multibillion-dollar black market. With regulation possibly ahead, healthcare companies and investors are rushing in even as safety concerns draw scrutiny.
用于追踪这条内容的来源与记录标识。
